Answers are grounded in this paper and cite their sources.
Neuropeptide Y (NPY) is a sympathetic co-transmitter that mediates vasoconstriction. However, there is evidence that it may also mediate dilation through a nitric oxide (NO)-dependent mechanism. OBJECTIVE: We used a swine model to examine how NPY influences cerebral vascular regulation and hypothesized that NPY would elicit both vasoconstrictor and vasodilatory effects, and that such effects would be modulated partially by NO signaling. Separately, Y1 receptor distribution (immunohistochemistry) and vasomotor responses to intra- and extraluminal NPY under control and NOS inhibition conditions were examined in isolated arteries. RESULTS: Intracarotid NPY infusions elicited transient dilation that was blocked by NOS inhibition. In isolated pial arteries, distinct populations of NPY-Y1 receptors were observed on both the vascular smooth muscle (VSM) and endothelium. Extraluminal application of NPY elicited vasoconstriction, while intraluminal delivery elicited vasodilation. NOS inhibition enhanced the magnitude of vasoconstriction in isolated pial arteries. Endothelial denudation, Y1 receptor antagonism, and NOS inhibition each blunted NPY-induced vasodilation. CONCLUSION: These data suggest both vasoconstrictor and vasodilatory effects of NPY are modulated partially by NO signaling.
No takes yet. Share an insight, caveat, or question.
Delgado et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: